Keratosis pilaris may also be treated with topical immunomodulators such as pimecrolimus (Elidel) or tacrolimus (Protopic)
It does not constitute medical advice, dosing recommendations, or treatment guidance
It does not show which compound is superior, faster, or safer, because no head-to-head study human or animal has ever compared them
However, a responsible medical discussion should distinguish between thymosin beta-4 research, TB-500 marketing claims, and the evidence needed to support patient care decisions
For a 5 mg vial with a target dose of 250-500 mcg twice daily, adding 2 mL of bacteriostatic water creates a 2.5 mg/mL concentration
Our BPC-157 Prime includes a highly bioavailable form of curcumin, called tetrahydrocurcumin